Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362318 · ClinicalTrials.gov registry record · NA
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free
A NA study of Lung Cancer and Smoking, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT05362318: Completed NA study of Lung Cancer and Smoking, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05362318 is a NA study of Lung Cancer and Smoking that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 21 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05362318, a NA study of Lung Cancer and Smoking, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
Primary Outcome
Percentage of participants who meet inclusion criteria
Conditions Studied
Interventions
- DRUG Nicotine patch and lozenges
- BEHAVIORAL Telephone counseling sessions
- BEHAVIORAL Access to a web-based video
- BEHAVIORAL Florida Tobacco Quitline
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2023-01-28 |
| Phase | NA |
What the finished NCT05362318 record still lists
NCT05362318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Nicotine patch and lozenges is the first listed.
NCT05362318 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05362318 about?
NCT05362318 is a clinical study titled "Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free". The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
What is the current status of trial NCT05362318?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-06-07. Estimated completion is 2023-01-28.
What conditions does trial NCT05362318 study?
This clinical trial studies the following conditions: Lung Cancer, Smoking, Tobacco Use.
What interventions are being tested in trial NCT05362318?
The interventions under investigation include: Nicotine patch and lozenges (DRUG), Telephone counseling sessions (BEHAVIORAL), Access to a web-based video (BEHAVIORAL), Florida Tobacco Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT05362318?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05362318 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05362318's enrollment target sits among peer trials
21 352nd of 409 higher than 55 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI